Roskamp Institute Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2011
NCT01607619
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Roskamp Institute Inc. | The Roskamp Institute Inc